InvestorsHub Logo
Followers 785
Posts 128093
Boards Moderated 9
Alias Born 09/26/2011

Re: Penny Roger$ post# 1141

Thursday, 03/07/2013 11:08:53 AM

Thursday, March 07, 2013 11:08:53 AM

Post# of 1171
$IMMB ~ Recent Press Releases:



News Disclaimer - The following Press Releases have not been investigated by StockGoodies, therefore we have no idea if the content of this news is based on Fact or Fiction. Although the links for the following press releases may be from a familiar and reputable company, you should NOT assume that a press wire hosted by a website you are familiar with is accurate just because it is on their site. StockGoodies will not be held responsible for any news release including and not limited to misleading or non-factual content, or the accuracy of the identity of the given source of the press release.

Marketwire - (March 7)

Immunotech Announces Canadian Special Access Program Could Allow Legal Treatment of Company's Patented (IPF-ITV-1) AIDS-HIV Treatment

http://finance.yahoo.com/news/immunotech-announces-canadian-special-access-141200702.html

Marketwire - (March 1)
Immunotech Relocates to New Research & Development Laboratory Facility
http://finance.yahoo.com/news/immunotech-relocates-research-development-laboratory-141500581.html

PR Newswire - (February 20)
Immunotech Laboratories Inc. Announces Clinical Trials Updates For Company's AIDS-HIV "IPF" Medicines
http://finance.yahoo.com/news/immunotech-laboratories-inc-announces-clinical-183200464.html

Marketwire - (February 19)
Immunotech Laboratories, Inc. Announces Analyst Report Issued by Market Advisors, Inc.
http://finance.yahoo.com/news/immunotech-laboratories-inc-announces-analyst-141500569.html

PR Newswire - (February 13)
Immunotech Laboratories Receives $2M Funding Approval To Begin European Clinical Trials Testing For Company's Patented "IPF" HIV-AIDS Medicines
http://finance.yahoo.com/news/immunotech-laboratories-receives-2m-funding-142000938.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.